HCmed Innovations CoTPE:6934 -2.16%11 Gross Margin % is 64.96% as of Dec. 2025, which is 161% above its 10-year median of 24.86. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 53.17% on this metric.
The historical rank and industry rank for HCmed Innovations Co's Gross Margin % or its related term are showing as below:
TPE:6934'
s Gross Margin % Range Over the Past 10 Years
Min: -474.96 Med: 24.86 Max: 70.37
Current: 49.77
During the past 5 years, the highestGross Margin % of HCmed Innovations Co was 70.37%. The lowest was -474.96%. And the median was 24.86%.
TPE:6934's Gross Margin % is ranked worse than 53.17% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs TPE:6934: 49.77
HCmed Innovations Co had a gross margin of 64.96% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for HCmed Innovations Co was 0.00% per year.
HCmed Innovations Co (TPE:6934) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
HCmed Innovations Co had a gross margin of 64.96% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
HCmed Innovations Co Gross Margin % Related Terms
HCmed Innovations Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for HCmed Innovations Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6934 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, HCmed Innovations Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCmed Innovations Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where HCmed Innovations Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
HCmed Innovations Co (TPE:6934) has a Gross Margin % of 64.96% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on HCmed Innovations Co and its competitors. This is 161% above median its historical median of 24.86. According to the industry distribution chart, HCmed Innovations Co ranks #428 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 53.2%.
Is HCmed Innovations Co's Gross Margin % too high?
HCmed Innovations Co's current Gross Margin % of 64.96% is 161% above median its 10-year median of 24.86. The Medical Devices & Instruments industry median Gross Margin % is 52.03. HCmed Innovations Co's value of 64.96% is 24.9% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #428 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #428 out of 805 companies for Gross Margin %. This places HCmed Innovations Co in the lower half of its industry. The industry median Gross Margin % is 52.03. HCmed Innovations Co's value of 64.96% is 24.9% above this benchmark. While the company's 10-year median is 24.86 vs. the industry median of 52.03, HCmed Innovations Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current Gross Margin % of 64.96% is 24.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current Gross Margin % is 64.96%, which is 161% above median its own 10-year median of 24.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current Gross Margin % of 64.96%. The current Gross Margin % is 64.96%, which is 161% above median its 10-year median of 24.86 and 24.9% above the Medical Devices & Instruments industry median of 52.03. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current Gross Margin % is 64.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score
Get the complete analysis for TPE:6934
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6934 has been successfully added to your 
